Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Roche (SWX:ROG) and TRMS withdrew an sNDA for the inclusion of the Biojector 2000 (B2000) needle-free injection device
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury